Related Experiment Videos

Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening

Insights

Delayed diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is common without newborn screening. This impacts timely intervention for affected infants and children.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands.
  • 21-hydroxylase deficiency is the most common form of CAH.
  • Early diagnosis is crucial for managing CAH and preventing complications.

Purpose of the Study:

  • To review medical records of patients with 21-hydroxylase deficiency CAH.
  • To document the ages at diagnosis in the absence of newborn screening.
  • To identify common presenting symptoms in infants and children.

Main Methods:

  • Retrospective review of medical records.
  • Analysis of patient data from 1956 to 1979.
  • Inclusion of patients diagnosed with 21-hydroxylase deficiency CAH.

Main Results:

  • Average age at diagnosis was 12.6 months without newborn screening.
  • Females diagnosed at 7.3 months, males at 22.7 months.
  • Presenting symptoms included ambiguous genitalia, precocious puberty, and salt-losing crises.

Conclusions:

  • Newborn screening is essential for early diagnosis of CAH.
  • Delayed diagnosis can lead to significant health issues.
  • Timely diagnosis improves management outcomes for congenital adrenal hyperplasia.

Related Concept Videos